MLchartDataset catalogue

Tazverik

Term · Oncology and biomedicine · MLC-T-ONC-008540

A drug used to treat adults and children aged 16 years and older with a rare type of soft tissue sarcoma called epithelioid sarcoma and adults with certain types of follicular lymphoma. It is also being studied in the treatment of other types of cancer. Tazverik blocks certain enzymes involved in gene expression and cell division. Blocking these enzymes may help keep cancer cells from growing. Tazverik is a type of histone methyltransferase inhibitor. Also called tazemetostat hydrobromide.

Table 1. Record
IdentifierMLC-T-ONC-008540
FieldOncology and biomedicine
Synonymstazemetostat hydrobromide
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008540",
  "term": "Tazverik",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults and children aged 16 years and older with a rare type of soft tissue sarcoma called epithelioid sarcoma and adults with certain types of follicular lymphoma. It is also being studied in the treatment of other types of cancer. Tazverik blocks certain enzymes involved in gene expression and cell division. Blocking these enzymes may help keep cancer cells from growing. Tazverik is a type of histone methyltransferase inhibitor. Also called tazemetostat hydrobromide.",
  "synonyms": [
    "tazemetostat hydrobromide"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tazverik/"
}

Record 16,027 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.